Global Transrectal Ultrasound Market Overview
As per MRFR analysis, the Transrectal Ultrasound Market Size was estimated at 0.21(USD Billion) in 2023.The Transrectal Ultrasound Market Industry is expected to grow from 0.22 (USD Billion) in 2024 to 0.35 (USD Billion) by 2032. The Transrectal Ultrasound Market CAGR (growth rate) is expected to be around 6.0% during the forecast period (2024 - 2032).
Key Transrectal Ultrasound Market Trends Highlighted
In the next years, the global market for a transrectal ultrasound will continue to expand strongly due to the increasing number of prostate cancer cases as well as technological improvements and population aging as the awareness about prostate cancer and its various treatment procedures, such as transrectal ultrasound, the demand for these procedures is increasing. Changes in ultrasound imaging enhanced by high-frequency transducers and three-dimensional imaging improve and expand the diagnostic powers of transrectal ultrasound procedures. In addition, the increasing aging population, who are at higher risk for prostate cancer, is another considerable factor for the growth of the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Transrectal Ultrasound Market Drivers
Rising Prevalence of Prostate Cancer
Prostate cancer is among one of the most prevalent cancerous diseases for men, and its incidence is increasing across the globe. Considering the fact that the general population of elderly people is growing, more men will be diagnosed with prostate cancer. Therefore, the demand for transrectal ultrasound procedures is predicted to rise as well. TRUS is a minimally invasive imaging method that can help diagnose and monitor prostate cancer. The procedure is relatively safe and painless.
The size, shape, and microstructure of the prostate gland can be studied. In conclusion, an increase in the demand for TRUS is to be expected because the incidence of prostate cancer will be rising as well.
Technological Advancements in TRUS Systems
The Global Transrectal Ultrasound Market Industry has witnessed significant technological advancements in recent years. These advancements have led to the development of new TRUS systems that offer improved image quality, faster scanning speeds, and greater ease of use. For example, some of the latest TRUS systems use artificial intelligence (AI) to automatically detect and classify abnormalities in the prostate gland. These advancements have made TRUS a more powerful and versatile tool for diagnosing and monitoring prostate cancer.
Increasing Awareness of TRUS Procedures
The growth in the awareness of TRUS procedures can be attributed as a key driver, driving the Global Transrectal Ultrasound Market Industry. Earlier, the process of TRUS was considered a highly uncomfortable and invasive procedure. However, the current technologies have made the process a highly comfortable option and less painful option. In the current days, most healthcare providers, as well as patients, are aware of the benefits of the TRUS, and hence, increasing awareness of this technique is another key driver of the growth of the Global Transrectal Ultrasound Market Industry.
Transrectal Ultrasound Market Segment Insights
Transrectal Ultrasound Market End-User Insights
The Global Transrectal Ultrasound Market segmentation offers vital insights into the diverse end-user segments that drive market growth. Among these segments, hospitals, ambulatory surgical centers, urology clinics, and research institutes play significant roles in shaping the market landscape. Hospitals: Hospitals represent a major end-user segment in the Global Transrectal Ultrasound Market. With advanced healthcare facilities and a wide range of services, hospitals cater to a large patient population. The increasing prevalence of prostate cancer and other urological conditions has led to a rise in the demand for transrectal ultrasound procedures in hospitals.
The availability of skilled professionals and sophisticated equipment positions hospitals as key end-users in the market. Ambulatory Surgical Centers: Ambulatory surgical centers (ASCs) are gaining popularity as a cost-effective alternative to hospitals for certain medical procedures. The growing number of ASCs offering transrectal ultrasound services has contributed to the market growth. ASCs provide convenient access to specialized care, reduced waiting times, and a more comfortable patient experience, driving their demand in the market. Urology Clinics: Urology clinics specialize in the diagnosis and treatment of urinary tract and male reproductive system disorders.
These clinics are equipped with specialized equipment and have experienced urologists who perform transrectal ultrasound procedures. The growing focus on early detection and management of urological conditions has increased the demand for transrectal ultrasound services in urology clinics, contributing to their significance in the market. Research Institutes: Research institutes play a crucial role in advancing medical technology and expanding the applications of transrectal ultrasound. These institutes conduct research on new techniques, develop innovative devices, and contribute to the overall growth of the market.
The increasing demand for transrectal ultrasound procedures, technological advancements, and growing awareness of prostate cancer are key factors driving the market growth.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Transrectal Ultrasound Market Application Insights
The principal applications of the global transrectal ultrasound market include Prostate Cancer Diagnosis, Prostate Biopsy, Bladder Cancer Diagnosis, and Other Applications. The Prostate Cancer Diagnosis segment held the largest market in 2023. The growth of this segment is associated with the increasing prevalence of the critical disease and the rising adoption of the ultrasound technique to detect and diagnose prostate cancer at its early stages. The Prostate Biopsy segment is also likely to experience an impressive growth rate. The demand for more minimally invasive and safer techniques to perform a prostate biopsy is increasing.
Fortunately, the technology allows physicians to perform TRUS-guided biopsies more accurately. The Bladder Cancer Diagnosis segment is expected to experience moderate growth. The increasing incidence of the disease, coupled with the effectiveness of transrectal ultrasound to detect bladder tumors, will foster the growth of the segment. Finally, Other Applications refer to the ability to perform TRUS to diagnose and monitor a myriad of other conditions, such as pelvic pain, prostatitis, and infertility. With this regard, the segment is likely to experience a steady growth rate.
Transrectal Ultrasound Market Image Guidance Technology Insights
The Global Transrectal Ultrasound Market is segmented based on Image Guidance Technology into Two-Dimensional (2D) Imaging, Three-Dimensional (3D) Imaging, and Four-Dimensional (4D) Imaging. In 2023, the 2D Imaging segment held the largest market share, accounting for over 60% of the global market revenue. The 3D Imaging segment is expected to grow at the highest CAGR during the forecast period, owing to the increasing adoption of advanced imaging techniques in prostate cancer diagnosis and treatment. The 4D Imaging segment is expected to witness a moderate growth rate due to its limited applications in transrectal ultrasound procedures.
Transrectal Ultrasound Market Probe Type Insights
The Global Transrectal Ultrasound Market is segmented by Probe Type into Rigid Probes and Flexible Probes. In 2023, the Rigid Probes segment accounted for a larger revenue share of the market, owing to their wide usage in prostate cancer diagnosis and treatment. However, the Flexible Probes segment is expected to witness a higher growth rate during the forecast period due to their increasing adoption of minimally invasive procedures and improved patient comfort. The market growth is attributed to the rising prevalence of prostate cancer, increasing awareness about early detection and diagnosis, and technological advancements in ultrasound imaging.
Transrectal Ultrasound Market Regional Insights
The Global Transrectal Ultrasound Market is segmented into North America, Europe, APAC, South America, and MEA. North America is the largest regional market for transrectal ultrasound, accounting for over 35% of the global market revenue in 2023. The high adoption of advanced healthcare technologies, well-established healthcare infrastructure, and presence of major market players contribute to the dominance of this region. Europe holds the second-largest share in the global market, driven by increasing healthcare expenditure, rising awareness about prostate cancer screening, and favorable reimbursement policies.
APAC is expected to witness significant growth in the coming years, owing to the rising prevalence of prostate cancer, increasing healthcare investments, and expanding access to healthcare services in emerging economies such as China and India. South America and MEA have a relatively smaller market share but are expected to show steady growth due to improving healthcare infrastructure and increasing awareness about prostate cancer screening.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Transrectal Ultrasound Market Key Players And Competitive Insights
Major players in the Transrectal Ultrasound Market industry are constantly striving to gain a competitive edge in the market. Leading Transrectal Ultrasound Market players are focusing on developing innovative products and expanding their product portfolios to cater to the growing demand for advanced and efficient Transrectal Ultrasound devices. Strategic partnerships, collaborations, and mergers and acquisitions are common strategies adopted by Transrectal Ultrasound Market players to strengthen their market position. Research and development initiatives are also crucial for Transrectal Ultrasound Market development, as advancements in technology drive product innovation and market growth.
Leading Transrectal Ultrasound Market player Siemens Healthineers is renowned for its comprehensive portfolio of medical imaging solutions, including advanced Transrectal Ultrasound systems. The company's commitment to innovation has resulted in the development of cutting-edge technologies such as the ACUSON Redwood Ultrasound System, which offers exceptional image quality and advanced features for prostate imaging. Siemens Healthineers' global presence and strong brand reputation contribute to its leading position in the Transrectal Ultrasound Market industry.
Another prominent competitor, GE Healthcare, is widely recognized for its expertise in manufacturing and supplying medical imaging equipment. The company's Transrectal Ultrasound systems are known for their high performance and reliability. GE Healthcare's focus on customer-centric solutions has led to the development of user-friendly systems that enhance the diagnostic capabilities of healthcare providers. Through strategic partnerships and collaborations, GE Healthcare continues to expand its reach in the global Transrectal Ultrasound Market.
Key Companies in the Transrectal Ultrasound Market Include:
- Hitachi
- Esaote
- Aloka
- Chison Medical Imaging
- Siemens Healthineers
- Medtronic
- Zonare Medical Systems
- Neusoft Medical Systems
- Mindray Medical International
- Terason
- UST
- Koninklijke Philips N.V.
- Canon Medical Systems
- Edan Instruments
- GE Healthcare
Transrectal Ultrasound Market Industry Developments
The increasing prevalence of prostate cancer, rising demand for minimally invasive procedures, and technological advancements are key factors driving market growth. The market is witnessing collaborations and partnerships among key players to enhance product portfolios and expand geographical reach.
Recent news developments include the launch of new products, such as BK Medical's Flex Focus 800 and Exact Imaging's ExactVu micro-ultrasound system. Furthermore, the integration of AI and machine learning in transrectal ultrasound systems is expected to offer improved diagnostic accuracy and efficiency, driving future market growth.
Transrectal Ultrasound Market Segmentation Insights
Transrectal Ultrasound Market End-User Outlook
- Hospitals
- Ambulatory Surgical Centers
- Urology Clinics
- Research Institutes
Transrectal Ultrasound Market Application Outlook
- Prostate Cancer Diagnosis
- Prostate Biopsy
- Bladder Cancer Diagnosis
- Other Applications
Transrectal Ultrasound Market Image Guidance Technology Outlook
- Two-Dimensional (2D) Imaging
- Three-Dimensional (3D) Imaging
- Four-Dimensional (4D) Imaging
Transrectal Ultrasound Market Probe Type Outlook
- Rigid Probes
- Flexible Probes
Transrectal Ultrasound Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2023 |
0.21(USD Billion) |
| Market Size 2024 |
0.22(USD Billion) |
| Market Size 2032 |
0.35(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
6.0% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Hitachi, Esaote, Aloka, Chison Medical Imaging, Siemens Healthineers, Medtronic, Zonare Medical Systems, Neusoft Medical Systems, Mindray Medical International, Terason, UST, Koninklijke Philips N.V., Canon Medical Systems, Edan Instruments, GE Healthcare |
| Segments Covered |
End-User, Application, Image Guidance Technology, Probe Type, Regional |
| Key Market Opportunities |
Prostate cancer diagnosis Virtual biopsy using fusion technology Imaging for colorectal cancer Pelvic organ imaging Bladder assessment |
| Key Market Dynamics |
Growing cancer burden Increasing use of advanced technologies Technological advancements Rising adoption of minimally invasive procedures Expanding healthcare infrastructure |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Transrectal Ultrasound Market is expected to reach USD 0.35 billion by 2032, exhibiting a CAGR of 6.0% during the forecast period (2024-2032).v
North America is expected to dominate the Transrectal Ultrasound Market throughout the forecast period due to the presence of well-established healthcare infrastructure, the high prevalence of prostate cancer, and favorable reimbursement policies.
The key growth drivers of the Transrectal Ultrasound Market include the rising incidence of prostate cancer, increasing adoption of minimally invasive procedures, technological advancements, and growing awareness about prostate health.
The key competitors in the Transrectal Ultrasound Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Hitachi Medical Systems, and Esaote SpA.
The major applications of Transrectal Ultrasound include prostate cancer detection, biopsy, and treatment monitoring, as well as evaluation of other pelvic organs such as the bladder, seminal vesicles, and rectum.
The COVID-19 pandemic had a moderate impact on the Transrectal Ultrasound Market due to disruptions in elective procedures and supply chains. However, the market is expected to recover in the post-pandemic period as healthcare systems resume normal operations.
Emerging trends in the Transrectal Ultrasound Market include the development of 3D and 4D ultrasound systems, the integration of artificial intelligence for image analysis, and the use of transrectal ultrasound-guided prostate biopsies.
The challenges faced by the Transrectal Ultrasound Market include the high cost of equipment, limited availability of skilled professionals, and the potential for discomfort or pain during the procedure.
The future outlook of the Transrectal Ultrasound Market is positive due to the increasing prevalence of prostate cancer, technological advancements, and growing awareness about prostate health. The market is expected to continue growing in the coming years.
The key opportunities for growth in the Transrectal Ultrasound Market include the development of new and innovative technologies, expansion into emerging markets, and increasing collaboration between manufacturers and healthcare providers.
